Ramipril
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Cardiac & Hypertension treatment.
🧴 Clinical Application
Take orally once or twice daily with a glass of water, with or without meals. Maintain consistent daily timing. First dose should preferably be taken at bedtime to prevent first-dose hypotension.
⚠️ Side Effects
Common: Persistent dry hacking cough (due to bradykinin accumulation), dizziness, headache, fatigue, nausea, orthostatic hypotension. Rare/Severe: Boxed warning: Fetal toxicity in pregnancy; life-threatening angioedema (swelling of face, lips, tongue, larynx, gut), hyperkalemia, acute renal failure, and neutropenia/agranulocytosis.
🛡️ Safety Warnings
Black box warning: Fetal toxicity; discontinue immediately if pregnancy is detected. Absolute contraindication in patients with a history of ACE inhibitor-associated angioedema and bilateral renal artery stenosis. Monitor serum creatinine and potassium regularly. Do not take potassium supplements.
Jan Aushadhi Products containing Ramipril
Found 10 generic formulation(s) containing this active ingredient.
Ramipril Tablets 2.5 mg
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Ramipril Tablets 5 mg
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Ramipril 5mg + Hydrochlorothiazide 12.5mg Tablets
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Ramipril 5mg + Amlodipine 5mg Tablets
Amlodipine (or S-Amlodipine, the pure chirally active enantiomer with lower incidence of ankle edema) is a third-generation dihydropyridine calcium channel blocker on the WHO Model List of Essential Medicines. It inhibits transmembrane influx of extracellular calcium ions into vascular smooth muscle and cardiac muscle through L-type channels, resulting in potent peripheral arterial and coronary vasodilation with an exceptionally long half-life (30-50 hours). Indicated for essential hypertension, chronic stable angina pectoris, and vasospastic (Prinzmetal's) angina.
Metoprolol 50mg (Extended Release) + Ramipril 5mg Tablet
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Metoprolol Succinate 25mg (Extended release) + Ramipril 2.5mg Tablets
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Ramipril Tablets 10mg
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Atorvastatin (10mg) + Aspirin (75mg) + Ramipril (5mg) Capsule
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Ramipril 2.5mg + Hydrochlorothiazide12.5mg Tablets
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Ramipril Tablets 1.25mg
Angiotensin Converting Enzyme (ACE) Inhibitor on the WHO Model List of Essential Medicines. It blocks the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing peripheral arterial resistance, decreasing aldosterone secretion, and inhibiting the enzymatic degradation of bradykinin, producing potent vasodilation and cardioprotection. Indicated for essential hypertension, heart failure with reduced ejection fraction (HFrEF), post-myocardial infarction, and diabetic nephropathy.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Ramipril.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Ramipril Tablets 2.5 mg | 10's | ₹7.94 | RAMISTAR, CARDACE, RAMI RACE, RAMIPRES, HOPACE | ₹47.23 | 83% Save |
| Ramipril Tablets 5 mg | 10's | ₹10.32 | RAMISTAR, CARDACE, RAMI RACE, RAMIPRES, HOPACE | ₹78.61 | 87% Save |
| Ramipril 5mg + Hydrochlorothiazide 12.5mg Tablets | 10's | ₹13.13 | RAMISTAR, CARDACE, RAMIHART, RAMCOR H, MACPRIL | ₹199.10 | 93% Save |
| Ramipril 5mg + Amlodipine 5mg Tablets | 10's | ₹23.44 | CARDACE, RAMISTAR, REMINIL | ₹184.64 | 87% Save |
| Metoprolol 50mg (Extended Release) + Ramipril 5mg Tablet | 10's | ₹84.38 | PROLOMET R, CARDACE, STARPRESS, EMBETA, MET XL R | ₹305.07 | 72% Save |
| Metoprolol Succinate 25mg (Extended release) + Ramipril 2.5mg Tablets | 10's | ₹23.44 | PROLOMET, CARDACE, STARPRESS, RAMISTAR M XL, VELOL | ₹310.75 | 92% Save |
| Ramipril Tablets 10mg | 10's | ₹18.75 | CARDACE, RAMI RACE, RAMISTAR | ₹241.19 | 92% Save |
| Atorvastatin (10mg) + Aspirin (75mg) + Ramipril (5mg) Capsule | 10's | Under Process | N/A | N/A | N/A |
| Ramipril 2.5mg + Hydrochlorothiazide12.5mg Tablets | 10's | ₹70.31 | RAMISTAR H, CARDACE, RAMI RACE, RAMCOR, MACPRIL | ₹122.90 | 43% Save |
| Ramipril Tablets 1.25mg | 10's | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Ramipril generics.